GlassScriptPhysician profile
Paul O Arnold
NPI 1992828693
$1,447.18
in general payments reported to CMS, 2019-2025
15 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $79.59 · 2021: $210 · 2022: $365 · 2023: $215 · 2024: $127 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $590.53 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Scientific Affairs, LLC | $234.10 | 2021-2022 | |
| Madrigal Pharmaceuticals | $90.54 | 2025 | Rezdiffra |
| E.R. Squibb & Sons, L.L.C. | $88.45 | 2022 | |
| Medtronic, INC. | $85.01 | 2022-2025 | Cd Horizon Spinal System, Hawkone |
| Boston Scientific Corporation | $73.71 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.64 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $47.89 | 2021 | |
| Janssen Biotech, INC. | $43.70 | 2022-2024 | Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.90 | 2019-2024 | Trulance |
| Genzyme Corporation | $26.19 | 2024 | |
| Ardelyx, INC. | $20.48 | 2025 | Ibsrela |
| Ethicon US, LLC | $20.33 | 2024 | Linx Reflux Management System |
| Aimmune Therapeutics, INC. | $15.75 | 2025 | Zenpep |
| Pfizer INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.